Neuroprotective effect of aminoguanidine on iron-induced neurotoxicity

Brain Research Bulletin

Volumn 76, Issue 1-2, 2008, Pages 57-62

  Bostanci, M Ömer ^a   Baǧirici, Faruk ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Aminoguanidine; Cell death; Hippocampus; Iron; Stereology

Indexed keywords

AMINOGUANIDINE; FERRIC CHLORIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; HISTOPATHOLOGY; IRON OVERLOAD; MALE; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

ANIMALS; ENZYME INHIBITORS; FERRIC COMPOUNDS; GUANIDINES; HIPPOCAMPUS; MALE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NOXAE; RATS; RATS, WISTAR;

EID: 41449103981     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2007.11.011     Document Type: Article

References (50)

1. Aisen P., Wessling-Resnick M., and Leibold E.A. Iron metabolism. Curr. Opin. Chem. Biol. 3 (1999) 200-206
2. Aust S.D., Morehouse L.A., and Thomas C.E. Role of metals in oxygen radicals reactions. J. Free Rad. Biol. Med. 1 (1985) 3-25
3. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87 (1990) 1620-1624
4. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am. J. Physiol. 271 (1996) 1424-1437
5. Bostanci M.O., Bagirici F., and Canan S. A calcium channel blocker flunarizine attenuates the neurotoxic effects of iron. Cell. Biol. Toxicol. 22 (2006) 119-125
6. Bostanci M.O., Bagirici F., and Korkmaz A. The neurotoxic effect of iron on pyramidal cell number in rat hippocampus: a stereological study. Neurosci. Res. Commun. 32 (2003) 151-159
7. Braughler J.M., Duncan L.A., and Chase R.L. The involvement of iron in lipid peroxidation. J. Biol. Chem. 261 (1986) 10282-10289
8. Cash D., Beech J.S., Rayne R.C., Bath P.M.W., Meldrum B.S., and Williams S.C.R. Neuroprotective effect of aminoguanidine on transient focal ischemia in the rat brain. Brain Res. 905 (2001) 91-103
9. Danielisova V., Nemethova M., and Burda J. The protective effect of aminoguanidine on cerebral ischemic damage in the rat brain. Physiol. Res. 53 (2004) 533-540
10. Deibel M.A., Ehmann W.D., and Markesbery W.R. Copper, iron and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 143 (1996) 137-142
11. Esplugues J.V. NO as a signalling molecule in the nervous system. Br. J. Pharmacol. 135 (2002) 1079-1095
12. Garthwaite J., and Boulton C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57 (1995) 683-706
13. Gokce F.M., Bagirici F., Kaplan S., Demir S., Ayyildiz M., and Marangoz C. A NOS inhibitor aminoguanidine reduces zinc-induced neuron loss in rat hippocampus. Neurosci. Res. Commun. 33 (2003) 53-62
14. Griffiths M.J.D., Messent M., Curzen N.P., and Evans T.W. Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase. Am. J. Res. Crit. Care Med. 152 (1995) 1599-1604
15. Gross S.S., and Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57 (1995) 737-769
16. Halliwell B.H., and Gutteridge J.M.C. Free Radicals in Biology and Medicine (1989), Oxford University Press, Oxford
17. Iadecola C., Zhang F., Casey R., Clark H.B., and Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 27 (1996) 1373-1380
18. Iadecola C., Zhang F., Casey R., Nagayama M., and Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17 (1997) 9157-9164
19. Iadecola C., Zhang F., and Xu X. Inhibition of inducible nitric oxide synthase gene expression in brain following focal cerebral ischemia. Am. J. Physiol. 268 (1995) 286-292
20. Inoue M., Ohgiya N., and Yamamoto M. Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats. Brain Res. 800 (1998) 319-322
21. Ioannidis I., and de Groot H. Cytotoxicity of nitric oxide in FU5 hepatoma cells: evidence for co-operative action with hydrogen peroxide. Biochem. J. 296 (1993) 341-345
22. Ivanova S., Botchkina G.I., Al-Abed Y., Meistrell M., Betliwalla F., Dubinsky J.M., Iadecola C., Wang H., Gregersen P.K., Eaton J.W., and Tracey K.J. Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J. Exp. Med. 188 (1998) 327-340
23. Leib S.L., Kim Y.S., Black S.M., Tureen J.H., and Tauber M.G. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J. Infect. Dis. 177 (1998) 692-700
24. Lin A.M.Y. Recovery by NO of the iron-attenuated dopamine dynamics in nigrostriatal system of rat brain. Neurosci. Res. 34 (1999) 133-139
25. Liu X., Miller M.J.S., Joshi M.S., Thomas D.D., and Lancaster J.R. Accelerated reaction of nitric oxide with oxygen within the hydrophobic interior of biological membranes. Proc. Natl. Acad. Sci. USA 95 (1998) 2175-2179
26. Meyerhoff J.L., Lee J.K., Rittase B.W., Tsang A.Y., and Yourick D.L. Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the rat. Brain Res. 1016 (2004) 139-144
27. Moos T. Brain iron homeostasis. Dan. Med. Bull. 49 (2002) 279-301
28. Murphy M.P., Packer M.A., Scarlett J.L., and Martin S.W. Peroxynitrite: a biologically significant oxidant. Gen. Pharmacol. 31 (1998) 179-186
29. Nathan C. Inducible nitric oxide synthase: what difference does it make?. J. Clin. Invest. 100 (1997) 2417-2423
30. O'Neill M.J., Hicks C., Ward M., and Panetta J.A. Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischemia. Brain Res. 760 (1997) 170-178
31. Pantopoulos K., Weiss G., and Hentze M. Nitric oxide and the post-transcriptional control of cellular iron traffic. Trends Cell Biol. 4 (1994) 82-86
32. Paxinos G., and Watson C. The Rat Brain in the Stereotaxic Coordinates. fourth ed. (1998), Academic Press, London
33. Qian Z.M., Wang Q., and Pu Y. Brain iron and neurological disorders. Chin. Med. J. 110 (1997) 455-458
34. Rauhala P., Sziraki I., and Chiueh C.C. Peroxidation of brain lipids in vitro: nitric oxide versus hydroxyl radicals. Free Rad. Biol. Med. 21 (1996) 391-394
35. Rodriguez-Martin E., Casarejos M.J., de Canals S., Bernardo S., and Mena M.A. Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures. Neuropharmacology 43 (2002) 877-888
36. Samudralwer D.L., Diprete C.C., Ni B.-F., Ehmann W.D., and Markesbery W.R. Elemental imbalances in the olfactory pathway in Alzheimer's disease. J. Neurol. Sci. 130 (1995) 139-145
37. Schmitz C., and Hof P.R. Design-based stereology in neuroscience. Neuroscience 130 (2005) 813-831
38. Sharifi A.M., Mousavi S.H., Bakhshayesh M., Tehrani F.K., Mahmoudiana M., and Oryan S. Study of correlation between lead-induced cytotoxicity and nitric oxide production in PC12 cells. Toxicol. Lett. 160 (2005) 43-48
39. Suzuki S., Kassell N.F., and Lee K.S. Hemin activation of an inducible isoform of nitric oxide synthase in vascular smooth-muscle cells. J. Neurosurg. 83 (1995) 862-866
40. Swaiman K.F. Hallervorden-Spatz and brain iron metabolism. Arch. Neurol. 48 (1991) 1285-1293
41. Szabo C., and Thiemermann C. Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv. Pharmacol. 34 (1995) 113-153
42. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91 (1994) 2046-2050
43. Verrecchia C., Boulu R.G., and Plotkine M. Neuroprotective and deleterious effects of nitric oxide on focal cerebral ischemia-induced neuron death. Adv. Neuroimmunol. 5 (1995) 359-378
44. West M.J., Slomianka L., and Gundersen H.J.G. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Record. 231 (1991) 482-497
45. Willmore L.J., Hiramatsu M., Kochi H., and Mori A. Formation of superoxide radicals after FeCl3 injection into rat isocortex. Brain Res. 277 (1983) 393-396
46. Willmore L.J., and Triggs W.J. Iron-induced lipid peroxidation and brain injury responses. Int. J. Dev. Neurosci. 9 (1991) 175-180
47. Wink D.A., and Ford P.C. Nitric oxide reactions important to biological systems: a survey of some kinetics investigations. Method 7 (1995) 14-20
48. Yildiz G., Demiryurek A.T., Sahin-Erdemli I., and Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminiscence. Br. J. Pharmacol. 124 (1998) 905-910
49. Zhang F., and Iadecola C. Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage. Brain Res. 802 (1998) 104-110
50. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., and Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64 (1996) 123-133